1. Home
  2. REA vs ACIU Comparison

REA vs ACIU Comparison

Compare REA & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rare Earths Americas Inc. Common Stock

REA

Rare Earths Americas Inc. Common Stock

N/A

Current Price

$14.72

Market Cap

232.3M

ML Signal

N/A

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.53

Market Cap

247.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REA
ACIU
Founded
N/A
2003
Country
Switzerland
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.3M
247.6M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
REA
ACIU
Price
$14.72
$2.53
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
115.5K
198.5K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$706.75
Revenue Next Year
N/A
$321.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.95
$2.03
52 Week High
$17.84
$4.00

Technical Indicators

Market Signals
Indicator
REA
ACIU
Relative Strength Index (RSI) 55.70 56.94
Support Level $13.50 $2.51
Resistance Level $16.18 $2.66
Average True Range (ATR) 1.05 0.12
MACD 0.54 0.04
Stochastic Oscillator 76.44 67.29

Price Performance

Historical Comparison
REA
ACIU

About REA Rare Earths Americas Inc. Common Stock

Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goiás, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: